- AI
- Molecular Imaging
- CT
- X-Ray
- Ultrasound
- MRI
- Facility Management
- Mammography
Researchers clash over AAA screening's worth
Two European studies published on the same day have reached opposite conclusions about the cost-effectiveness of ultrasound screening exams for abdominal aortic aneurysm.
Two European studies published on the same day have reached opposite conclusions about the cost-effectiveness of ultrasound screening exams for abdominal aortic aneurysm.
Researchers in the U.K. came to a positive conclusion about the exam's cost-effectiveness based on nearly 70,000 subjects enrolled in the Multicenter Aneurysm Screening Study (MASS). A cost/benefit analysis showed average per-life-year gains below the National Health Service's benchmark of £25,000. Danish investigators, on the other hand, reported negative findings using a mathematical model and data from the literature and the Danish Vascular Registry to estimate costs and outcomes for a hypothetical population of Danish men aged 65 from screening to death. Their estimates showed the cost of screening per quality adjusted life year was $71,160, well beyond the local accepted benchmark of $49,530. Both studies were published online June 26 in the British Medical Journal.
Study Reaffirms Low Risk for csPCa with Biopsy Omission After Negative Prostate MRI
December 19th 2024In a new study involving nearly 600 biopsy-naïve men, researchers found that only 4 percent of those with negative prostate MRI had clinically significant prostate cancer after three years of active monitoring.
Study Examines Impact of Deep Learning on Fast MRI Protocols for Knee Pain
December 17th 2024Ten-minute and five-minute knee MRI exams with compressed sequences facilitated by deep learning offered nearly equivalent sensitivity and specificity as an 18-minute conventional MRI knee exam, according to research presented recently at the RSNA conference.
Can Radiomics Bolster Low-Dose CT Prognostic Assessment for High-Risk Lung Adenocarcinoma?
December 16th 2024A CT-based radiomic model offered over 10 percent higher specificity and positive predictive value for high-risk lung adenocarcinoma in comparison to a radiographic model, according to external validation testing in a recent study.
